Axial VC — 2020 Investments
2 investments dated 2020 · listed companies and verified rows first · show all
Enable Medicine builds an integrated biological data platform that organizes and links clinical, spatial, cellular, and molecular data from patients and studies into a unified index to accelerate therapeutic discovery and diagnostics for researchers.
AI & Machine LearningBiotechData & InfrastructureMenlo Park, US
Sunil Bodapati(Executive Officer, Director)inAaron Mayer(Director)in
Co-investorsBreyer CapitalInitialized CapitalWPSS InvestmentsInertia Ventures
Lyell develops CAR T-cell therapies for cancer patients by leveraging deep expertise in T-cell biology and oncology.
BiotechDeep TechHealthtechMedical DevicesBothell, US
Stan Riddell(Executive Officer)Richard Klausner(Executive Officer, Director, Promoter)Stephen Hill(Executive Officer)inHeather Turner(Executive Officer)inRichard Goold(Executive Officer)inMargo Roberts(Executive Officer)
Co-investorsARCH Venture PartnersForesite CapitalvenBio Partners8VC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.







